Announced Mon, 20 Jul · 12:54 IST
Board Meeting on Aug 11 to Consider Q1FY26 Financial Results
Results View source PDF
ZYDUSLIFE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+0.2%1-day move
₹1143.80
prior close
₹1165.70
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.1-0.1-0.1-0.1+0.2-1.6-3.0-3.0-3.1—————
Up moveDown movePending
AI summary
Zydus Lifesciences has informed BSE that its Board of Directors will meet on Tuesday, August 11, 2026 to consider and approve unaudited financial results for the quarter ended June 30, 2026 (Q1FY26), along with other agenda items. The trading window for directors and designated persons stays closed till August 13, 2026 and reopens on August 14, 2026 under insider trading rules. No financial numbers are disclosed in this notice.
Likely market impact
No material impact yet. Just advance notice of upcoming earnings. Investors should watch the Q1FY26 results on August 11 for performance updates.